Announced

Completed

Asabys and Buenavista led a $50m Series A round in Quibim.

Synopsis

Asabys, a life science venture capital firm, and Buenavista, a private equity firm, led a $50m Series A round in Quibim, a company developing AI-powered radiomics and imaging biomarkers, with participation from UI Investissements, GoHub, CDTI Innovación, Amadeus, APEX, Partech, Adara Ventures, Leadwind, Build Collective and Jonathan Milner. “Quibim’s mission is to turn imaging into a catalyst for precision health, and we are deeply grateful to both our new and current investors for their support [...] Our global expansion into the U.S. is a critical milestone as we work with pharmaceutical leaders and healthcare providers to unlock the power of imaging to revolutionize diagnostics and improve patient outcomes,” Angel Alberich-Bayarri, Quibim CEO and Co-Founder.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite